Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 5,800 shares, a growth of 75.8% from the April 30th total of 3,300 shares. Based on an average daily volume of 30,400 shares, the short-interest ratio is currently 0.2 days.

Apollomics Price Performance

Shares of APLMW stock opened at $0.02 on Monday. The company’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.03.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.